{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:50:55Z","timestamp":1761155455867},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ijrobp.2010.11.040","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T09:29:52Z","timestamp":1296206992000},"page":"690-695","source":"Crossref","is-referenced-by-count":18,"title":["Exclusive Alternating Chemotherapy and Radiotherapy in Nonmetastatic Inflammatory Breast Cancer: 20 Years of Follow-Up"],"prefix":"10.1016","volume":"82","author":[{"given":"C\u00e9line","family":"Bourgier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Lima","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Dunant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Spielmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Arriagada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Marsiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.11.040_bib1","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2004.04.068","article-title":"Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy","volume":"22","author":"Low","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02303668","article-title":"Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma","volume":"4","author":"Fleming","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1278-3218(00)80004-9","article-title":"[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer]","volume":"4","author":"Hasbini","year":"2000","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib4","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/1097-0142(19951201)76:11<2286::AID-CNCR2820761116>3.0.CO;2-L","article-title":"Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy","volume":"76","author":"Thomas","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/1097-0142(19800215)45:4<625::AID-CNCR2820450402>3.0.CO;2-V","article-title":"Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy","volume":"45","author":"Barker","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0360-3016(94)90416-2","article-title":"Analysis of the probability and risk of cause-specific failure","volume":"29","author":"Caplan","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1200\/JCO.1986.4.12.1765","article-title":"Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy","volume":"4","author":"Rouesse","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"77","key":"10.1016\/j.ijrobp.2010.11.040_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ijrobp.2009.06.042","article-title":"Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era","volume":"4","author":"Damast","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/07357909309018867","article-title":"Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer","volume":"11","author":"Mourali","year":"1993","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","article-title":"Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence","volume":"47","author":"Liao","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0360-3016(83)90089-5","article-title":"Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day","volume":"9","author":"Thames","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0360-3016(89)90060-6","article-title":"Multimodal treatment for inflammatory breast cancer","volume":"17","author":"Thoms","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002800050664","article-title":"Combined-modality treatment of inflammatory breast carcinoma: Twenty years of experience at M.D. Anderson Cancer Center","volume":"40","author":"Ueno","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.1995.13.2.314","article-title":"Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: A phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer","volume":"13","author":"Chevallier","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib18","first-page":"2578","article-title":"Pathological assessment of response to induction chemotherapy in breast cancer","volume":"46","author":"Feldman","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bjc.6690714","article-title":"First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: Toxicity and response (PEGASE 02 trial)","volume":"81","author":"Viens","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2009.23.5101","article-title":"Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: A secondary analysis of the GeparTrio trial data","volume":"28","author":"Costa","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000421-199210000-00002","article-title":"Inflammatory breast cancer: Integration of irradiation, surgery, and chemotherapy","volume":"15","author":"Pisansky","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib22","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ejca.2006.03.026","article-title":"Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: Results of a phase II study","volume":"42","author":"Bollet","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib23","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1200\/jco.2010.28.15_suppl.644","article-title":"Effect of preoperative concomitant chemoradiotherapy in chemotherapy-refractory breast cancer on feasibility of curative surgery and pathologic tumor response","volume":"28","author":"Ghorbel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2008.08.001","article-title":"Progressive inflammatory breast cancer in patient receiving chemotherapy: The importance of radiotherapy as a part of locoregional treatment","volume":"90","author":"Chargari","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01806692","article-title":"Combined modality treatment of locally advanced breast cancer: Adjuvant combination chemotherapy with and without doxorubicin","volume":"9","author":"Casper","year":"1987","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02307059","article-title":"Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy","volume":"2","author":"Bauer","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib27","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib28","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(20011001)92:7<1775::AID-CNCR1693>3.0.CO;2-E","article-title":"Paclitaxel in the multimodality treatment for inflammatory breast carcinoma","volume":"92","author":"Cristofanilli","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3816\/CBC.2004.n.004","article-title":"Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: The M.D. Anderson Cancer Center experience","volume":"4","author":"Cristofanilli","year":"2004","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02841860510029725","article-title":"Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study","volume":"44","author":"Kummel","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1704458","article-title":"Multivariate analysis of survival in inflammatory breast cancer: Impact of intensity of chemotherapy in multimodality treatment","volume":"33","author":"Bertucci","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib32","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/cncr.22227","article-title":"Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: Ten-year results from the French Adjuvant Study Group GETIS 02 Trial","volume":"107","author":"Veyret","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.11.040_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrclinonc.2009.73","article-title":"Molecular targets for treatment of inflammatory breast cancer","volume":"6","author":"Yamauchi","year":"2009","journal-title":"Nat Rev Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T05:57:17Z","timestamp":1543989437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610036618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0360301610036618"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.040","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}